Amundi’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-157,445
| Closed | -$15.1M | – | 1592 |
|
|
2025
Q2 | $15.1M | Sell |
157,445
-35,386
| -18% | -$3.35M | 0.01% | 762 |
|
|
2025
Q1 | $17.9M | Buy |
192,831
+192,808
| +838,296% | +$17.8M | 0.01% | 728 |
|
|
2024
Q4 | $2.12K | Sell |
23
-294,588
| -100% | -$27.1M | ﹤0.01% | 1988 |
|
|
2024
Q3 | $28.4M | Buy |
294,611
+18,000
| +7% | +$1.76M | 0.01% | 651 |
|
|
2024
Q2 | $26.9M | Buy |
276,611
+48,196
| +21% | +$4.47M | 0.01% | 650 |
|
|
2024
Q1 | $20.7M | Sell |
228,415
-6,025
| -3% | -$565K | 0.01% | 695 |
|
|
2023
Q4 | $21.9M | Sell |
234,440
-53,353
| -19% | -$4.98M | 0.01% | 701 |
|
|
2023
Q3 | $26.7M | Buy |
287,793
+162,549
| +130% | +$15M | 0.01% | 646 |
|
|
2023
Q2 | $11.4M | Buy |
125,244
+3,158
| +3% | +$259K | 0.01% | 817 |
|
|
2023
Q1 | $9.4M | Sell |
122,086
-19,452
| -14% | -$1.68M | 0.01% | 851 |
|
|
2022
Q4 | $11.5M | Buy |
141,538
+11,703
| +9% | +$1.06M | 0.01% | 825 |
|
|
2022
Q3 | $13M | Sell |
129,835
-95,944
| -42% | -$11.4M | 0.01% | 784 |
|
|
2022
Q2 | $27.5M | Buy |
225,779
+4,835
| +2% | +$618K | 0.02% | 558 |
|
|
2022
Q1 | $36.9M | Buy |
220,944
+54,443
| +33% | +$8.13M | 0.03% | 525 |
|
|
2021
Q4 | $24.4M | Sell |
166,501
-9,706
| -6% | -$1.56M | 0.02% | 635 |
|
|
2021
Q3 | $26.3M | Sell |
176,207
-19,786
| -10% | -$4.11M | 0.02% | 614 |
|
|
2021
Q2 | $48M | Buy |
+195,993
| New | +$51.4M | 0.03% | 454 |
|
Other funds holding AMED
Amundi's AMED Position: Q3 2025 in Review
Amundi sold out of Amedisys (AMED) in Q3 2025, closing a stake of 157,445 shares — an estimated $15.1M sold.
Amundi first reported a position in AMED in Q2 2021 and held it in 17 quarters. The position peaked at $48M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Amundi reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Amundi sold 157,445 Amedisys shares in Q3 2025, an estimated $15.1M.
- Amundi first reported a position in Amedisys in Q2 2021 and held it in 17 quarters.
- Amundi's Amedisys position peaked at $48M in Q2 2021.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Amundi's 13F filing for Q3 2025, filed 14 Nov 2025.